These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38535101)

  • 41. Cardiovascular metrics on CT pulmonary angiography in patients with pulmonary hypertension - re-evaluation under the updated guidelines of pulmonary hypertension.
    Liu A; Xu W; Xi L; Deng M; Yang H; Huang Q; Gao Q; Zhang P; Xie W; Huang Z; Liu M
    Insights Imaging; 2023 Oct; 14(1):179. PubMed ID: 37872384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Combined Pre and Postcapillary Pulmonary Hypertension on Survival after Transcatheter Aortic Valve Implantation.
    Sultan I; Fukui M; Bianco V; Brown JA; Kliner DE; Hickey G; Thoma FW; Lee JS; Schindler JT; Kilic A; Gleason TG; Cavalcante JL
    Am J Cardiol; 2020 Sep; 131():60-66. PubMed ID: 32713655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Updated definition of exercise pulmonary hypertension.
    Zeder K; Olschewski H; Kovacs G
    Breathe (Sheff); 2022 Dec; 18(4):220232. PubMed ID: 36865934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abnormal pulmonary hemodynamics during exercise is associated with exercise capacity in COPD.
    Sassmann T; Douschan P; Foris V; Tröster N; Zeder K; Brcic L; Tornyos A; Bachmaier G; Fuchsjäger M; Olschewski H; Kovacs G
    Respir Res; 2022 Dec; 23(1):331. PubMed ID: 36482405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
    Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Grünig E; Benjamin N; Distler O
    Ann Rheum Dis; 2020 Mar; 79(3):370-378. PubMed ID: 31818805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Vaskuläre Dyspnoe: Pulmonale Hypertonie].
    Serény D; Ulrich S; Berlier C
    Ther Umsch; 2023 Aug; 80(6):272-278. PubMed ID: 37855531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary arterial hypertension.
    Montani D; Günther S; Dorfmüller P; Perros F; Girerd B; Garcia G; Jaïs X; Savale L; Artaud-Macari E; Price LC; Humbert M; Simonneau G; Sitbon O
    Orphanet J Rare Dis; 2013 Jul; 8():97. PubMed ID: 23829793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carcinoembryonic antigen levels are increased with pulmonary output in pulmonary hypertension due to congenital heart disease.
    Zi-Yang Y; Kaixun Z; Dongling L; Zhou Y; Chengbin Z; Jimei C; Caojin Z
    J Int Med Res; 2020 Nov; 48(11):300060520964378. PubMed ID: 33203284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Definitions and diagnosis of pulmonary hypertension.
    Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?
    Sarı A; Şener YZ; Armağan B; Kılıç L; Kaya EB; Hekimsoy V; Karadağ Ö; Apras Bilgen Ş; Kiraz S; Ertenli I; Tokgozoğlu L; Akdoğan A
    Anatol J Cardiol; 2021 Jan; 25(1):30-35. PubMed ID: 33382047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty - A randomized controlled study.
    Aoki T; Sugimura K; Terui Y; Tatebe S; Fukui S; Miura M; Yamamoto S; Yaoita N; Suzuki H; Sato H; Kozu K; Konno R; Miyata S; Nochioka K; Satoh K; Shimokawa H
    Int J Cardiol Heart Vasc; 2020 Aug; 29():100579. PubMed ID: 32685661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.
    Maron BA; Brittain EL; Hess E; Waldo SW; Barón AE; Huang S; Goldstein RH; Assad T; Wertheim BM; Alba GA; Leopold JA; Olschewski H; Galiè N; Simonneau G; Kovacs G; Tedford RJ; Humbert M; Choudhary G
    Lancet Respir Med; 2020 Sep; 8(9):873-884. PubMed ID: 32730752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strong linear relationship between heart rate and mean pulmonary artery pressure in exercising patients with severe precapillary pulmonary hypertension.
    Chemla D; Castelain V; Hoette S; Creuzé N; Provencher S; Zhu K; Humbert M; Herve P
    Am J Physiol Heart Circ Physiol; 2013 Sep; 305(5):H769-77. PubMed ID: 23792679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary vascular response patterns during exercise in interstitial lung disease.
    Degani-Costa LH; Levarge B; Digumarthy SR; Eisman AS; Harris RS; Lewis GD
    Eur Respir J; 2015 Sep; 46(3):738-49. PubMed ID: 25976688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Impact of Breathing Hypoxic Gas and Oxygen on Pulmonary Hemodynamics in Patients With Pulmonary Hypertension.
    Carta AF; Lichtblau M; Berlier C; Saxer S; Schneider SR; Schwarz EI; Furian M; Bloch KE; Ulrich S
    Front Med (Lausanne); 2022; 9():791423. PubMed ID: 35223898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodynamic heterogeneity of connective tissue disease patients with borderline mean pulmonary artery pressure and its distinctive characters from those with normal pulmonary artery pressure: a retrospective study.
    Asari Y; Yamasaki Y; Tsuchida K; Suzuki K; Akashi YJ; Okazaki T; Ozaki S; Yamada H; Kawahata K
    Clin Rheumatol; 2018 Dec; 37(12):3373-3380. PubMed ID: 29777409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
    DuBrock HM; Del Valle KT; Krowka MJ
    Liver Transpl; 2022 Jul; 28(7):1224-1230. PubMed ID: 35106916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tricuspid Regurgitation Velocity and Mean Pressure Gradient for the Prediction of Pulmonary Hypertension According to the New Hemodynamic Definition.
    Mandoli GE; Landra F; Chiantini B; Sciaccaluga C; Pastore MC; Focardi M; Cavigli L; D'Ascenzi F; Bernazzali S; Maccherini M; Valente S; Cameli M; Henein M
    Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demographic, hemodynamic characteristics, and therapeutic trends of pulmonary hypertension patients: The Pulmonary Hypertension Mexican registry (REMEHIP).
    Jerjes-Sánchez C; Ramírez-Rivera A; Hernandez NZ; Cueto Robledo G; García-Aguilar H; Gutiérrez-Fajardo P; Seoane García de León M; Moreno Hoyos-Abril F; Ernesto Beltrán Gámez M; Elizalde J; Fccp TP; Sandoval J;
    Pulm Circ; 2024 Apr; 14(2):e12395. PubMed ID: 38887742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: Results from an international registry.
    Gayen SK; Baughman RP; Nathan SD; Wells AU; Kouranos V; Alhamad EH; Culver DA; Barney J; Carmoma EM; Cordova FC; Huitema M; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Price LC; Wort SJ; Shlobin OA; Gupta R
    Pulm Circ; 2023 Oct; 13(4):e12297. PubMed ID: 37840561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.